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ABSTRACT 
BACK GROUND 
Tissue regeneration is the biggest goal of rehabilitation therapies today, for 
which many products and techniques have been used (Tissucol, PRP, PDGF, PRF etc). 
Though none of the systems proved to be successful for an appropriate bio stimulation, 
as these techniques do not exploit the regenerative potential of the components of the 
whole blood. The concentrated growth factor technique envisages the use of all the 
separated blood phases which can be disposed individually in order to obtain the bio 
stimulation of related cells or tissues. 
The Concentrated Growth Factor as a regenerative tool for accelerated wound 
healing was developed by Sacco in 2006, taking advantage of presence of adult stem 
cells and growth factors when whole blood is processed in a specific cycle. This 
presentation is about the role of CGF in early accelerated tissue healing in minor oral 
surgical procedures of a health individual. 
Extraction of an impacted mandibular third molar is a common surgical 
procedure, although it still leads to several postoperative symptoms and complications. 
The study assessed the efficacy of concentrated growth factors in the healing process 
by checking the difference of tissue cytokines and other healing factors produced by the 
mucosa after extraction between sites treated with CGF and control sites and, at the 
same time, by evaluating the clinical efficacy of CGF in terms of reduced pain and 
facial swelling. This study was a split-mouth study, in which the patient becomes 
his/her own control, to eliminate any individual response differences toward CGF 
treatment. The parameters regarding inflammation and subsequent wound healing were 
all significantly higher at CGF sites than at control sites. The increase at PRGF sites of 
the two proinflammatory cytokines evaluated, interleukin (IL)-1β and IL-6, is 
accompanied by the increase of two anti-inflammatory cytokines, IL-10 and 
transforming growth factor-β. Furthermore, IL-1β and IL-6 induce fibroblast and 
keratinocyte proliferation, important events in wound healing. Postoperative pain and 
the swelling, measured at all experimental times, were reduced in the presence of CGF. 
Aim and Objectives: 
The purpose of this study is  to evaluate and compare utility and 
efficacy of concentrated growth factor on soft  t issue healing and bone 
healing following surgical removal of a mandibular impacted 3
rd
 molar 
with the control group.  
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Materials and Methods:  
Sampling procedure  Random selection of population  
No. of Groups  Two   
Control group (Group 1) &  
Experimental group (Group 2)  
Sample size  15 + 15=30 
Patient selection:  
 Patients were selected by means of volunteers’ recruitment 
process. Patients interested in the surgical removal of mandibular 3
rd
 
molars were included in the study. Symptomatic and asymptomatic 
patients were selected and inform consent form signed.  
This prospective randomized control blind study was carried out 
to evaluate  and compare utility and efficacy of concentrated growth 
factor on soft tissue healing and bone healing following surgical 
removal of mandibular impacted 3
rd
 molar in 15 patients by fulfilling 
the inclusion and indication criteria.  All patients had moderat ely 
difficult impacted lower third molar according to modified Pederson’s 
index. 
Conclusion:  
The results of this study indicates that  CGF is signiﬁcantly better 
in  regeneration of  bone around the surgical removal of mandibular 
molar when comparing with non-CGF groups. Although, CGF showed 
improvement in both soft tissue healing and bone formation, there is 
much differences in bone level changes on mesial  and distal  side of the 
surgical  removal of impacted teeth between two groups. CGF did 
attribute to be  a much simpler and a better platelet  concentrate, in 
promoting osseous regeneration. CGF also aided in increasing the 
density of bone around the surgical  removal of impacted 3
rd
  molar teeth 
from baseline to a much higher level. This attribute could be used in 
cases where bone mineralization is compromised. But the exact action of 
CGF on bone mineralization needs to be studied further.  
Key words :  
Impacted 3
rd
 molar,  Concentrated Growth factor.  
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INTRODUCTION 
 
Surgical extraction of impacted mandibular third molar is one of 
the most common minor surgical procedure performed by the Oral and 
Maxillofacial Surgeons  [1]. As with any surgical removal of impacted 
lower third molar is always associated with postoperative complications. 
In the orofacial area has physical,  psychological and esthetic 
ramifications of considerable degree.  It has been reported that  there is  a 
threefold decrease of adverse effects on quality of life  [2] due to 
postoperative complications such as pain,  swelling and trismus.  
 
The surgical  removal of third molar  (wisdom teeth) generally 
produces pain, trismus and facial  swelling in the postoperative period 
[3]. The many factors that contribute toward these conditions are 
complex, but originate in an inflammatory process initiated by surgical  
trauma [4]. The  postoperative  effect  of  wisdom  tooth surgery  on  
quality  of  l ife  is   reported  to  be  threefold greater in patients who 
experience pain, swelling and trismus (either  alone  or  in  
combination)  in  comparison to asymptomatic pati ents [5].  
 
Many clinicians have therefore stressed the need for better pain, 
swelling and trismus control  in patients who undergo third mo lar 
surgery [6]. There have been few attempts to study pat ients expectations 
regarding outcomes, although patients  perceptions of recovery following 
third molar surgery have been reported. [5,7-9]  
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Growth factors:  
Growth factors are proteins which regulate the complex processes 
of wound healing. Growth factors play a main role in cell migration, cell 
proliferation and angiogenesis in tissue regeneration phase.  These 
growth factors are mainly located in blood plasma and platelets. Platelet  
concentrate such as platelet  rich plasma (PRP) has been used to 
accelerate soft t issue healing for a long time. Platelet  rich fib rin was 
introduced by Choukroun for  the first t ime. The effect of Platelet rich 
plasma is controversial with regards to hard tissue regeneration. Platelet  
rich plasma needs complex protocols to prepare and chemical additives 
are required. But concentrated growth factors (CGF) overcome these 
disadvantages of Platelet rich plasma. The preparation of Concentrated 
growth factor is simple. Compared to Platelet rich fibrin, Concentrated 
growth factor is  attained by single  a centrifugation using special  
centrifuge.  
 
Concentrated Growth Factors (CGF) has been suggested to 
enhance the healing of bone grafts and enhance t he integration of bone 
in the extraction socket . Concentrated growth factor was first  developed 
by Sacco in 2006. It  can be used as a barrier membran e to accelerate soft  
tissue healing. Concentrated growth factor does not require any chemical 
or anticoagulants so it is free from viral transmission diseases.  
Concentrated growth factor is 100% autologous. Unlike Platelet rich 
plasma, Concentrated growth factors is  well  known to accelerate 
healing. Concentrated growth factors is also an alternative to bone 
substi tutes in sinus augmentation. One step protocol i s needed to obtain 
Introduction 
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Concentrated growth factors from the blood sample, unlike platelet rich 
plasma bone formation.  
 
Surgeons use Concentrated growth factors as  a barrier membrane 
to accelerate the soft tissue healing or can be mixed with bone graft  to 
accelerate new bone formation.Whether the use of CGF to enhance 
Osseointegration, thus leading to better success on surgical  removal of  
impacted tooth is yet  to be studied.  
Aims and Objective 
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AIMS AND OBJECTIVE 
 
The purpose of this study is  to evaluate and compare utility and 
efficacy of concentrated growth factor on soft  t issue healing and bone 
healing following surgical removal of a mandibular impacted 3
rd
 molar 
with the control group. 
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REVIEW OF LITERATURE  
 
R E Marx et al (1998)[14], found that  the Platelet -rich plasma is an 
autologous source of platelet -derived growth factor and transforming 
growth factor beta that is obtained by sequestering and concentrating 
platelets by gradient density centrifugation. This technique produced a 
concentration of human platelets of 338% and identified platelet -derived 
growth factor and transforming growth factor beta within them. 
Monoclonal antibody assessment of cancellous cellular marrow grafts 
demonstrated cells that were capable of responding to  the growth factors 
by bearing cell membrane receptors addit ional amount of growth factors 
obtained by adding PRP to grafts evidenced a radiographic maturation 
rate 1.62 to 2.16 times that of grafts without platelet - rich plasma.  
 
P Edward Anitua MD, DDS et al  (1999) ,[11] found that  the use of 
platelet rich growth factor provides conditions for obtaining more rapid 
and effective bone regeneration. Platelet  rich growth factor gel  which is 
a coagulated mass is  easy to manipulate,  but it  must be appl ied without 
delay to preserve growth factor activity.  In addition to these growth 
factors, other proteins carried platelets may act with other cytokines 
released from other cellular sources,  modulating hemostasis. These 
results suggest that reinforcing growth factor concentration through the 
application of PRGF in the wound improves soft tissue repair and bone 
regeneration. No negative effect has been found and the epithelialisation 
has been complete and significantly better than in areas not treated with 
PRGF. 
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A.Dugrillonetal et al (2002)[18], concluded that platelets are rich in 
growth factors and may contribute to an acc elerated t issue regeneration 
process. The therapeutic osteogenic effect of local platelet  
administration probably depends on the amount of growth factors 
delivered within.  To improve platelet -derived factor preparations,  the 
platelets have to be concentrated without loss of the granular growth 
factor load. An autologous procedure according to the Good 
Manufacture Practice (GMP) guidelines to prepare a high concentrate 
from platelet -rich plasma (cPRP) for clinical application in bone 
regeneration is necessary.  
 
Michael Tischler DDS et al (2002)[16],  concluded that the application 
of PRP offers the patient something that is safe from outside disease 
transmission or immunogenic reactions.  PRP preparation can be easily 
obtained in dental  office environment and can be used for various 
procedures being done. The growth factor enhancement is  especially 
applicable for patients who are healing impaired such as elderly.   
Platelet rich plasma appears to enhance both hard tissue  and soft  tissue 
healing through concentrated platelets and growth factors such as 
platelet derived growth factor (PDGF) and Transforming growth factor β 
(TGF –  β).  
 
Kazuhiro et al (2003)[19], concluded that  PRP has been thought, but not 
well demonstrated, to contain certain growth factors,  such as PDGF and 
TGF β, at  high concentrations. In general, it  has not been demonstrated 
that  these growth factors in PRP are involved in accelerating 
Review of Literature 
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regeneration of periodontal t issue damaged by periodontitis.  This study 
for the ﬁrst  time shown the PRP containing these growth factors 
efﬁciently and effectively regulated the proliferation of period ontal  
related cells in culture.  
 
G Weibrich et al (2004)[20], concluded that PRP seems to be able to 
activate the osseous regeneration processes under optimized conditions. 
The simulatory effect of PRP in vitro on the proliferation of osteoblasts 
seems to start  in vivo in the second week, can be evaluated statistic ally 
significant from the third week, and still  exists in the fourth week. The 
platelet concentration required for a positive PRP effect seems to span a 
small range of concentration. Advantageous biological effects seem to 
appear when PRP with a platelet concentration of approximately 
1000000/µl is used. At lower concentration the effect is suboptimal 
while higher concentration might have a paradoxically inhibitory effect .  
            
R L Eppley et al(2004)[12], found that the platelets can be sequestered 
and concentrated eight fold from whole blood without activating the 
platelets before desired. These platelets contain a host  of growth factors, 
such as PDGF-BB, TGF-[beta]1, VEGF, and EGF, whose levels are 
increased when platelets are concentrated into pla telet-rich plasma gel 
preparations. Platelet -rich plasma, and the associated fibrin clot, can 
potentially aid in wound repair and help to maintain hemostasis, or can 
be mixed with other t issues as an adjunct to their transplantation. 
However growth factor concentration varied from patient to patient.  
Review of Literature 
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Sufficient concentrates and release of these growth factors through 
autologous platelet gels may be capable of expediting wound healing.  
           
Khoury et al (2006)[10], concluded that promising accelerated 
osseointegration results have been obtained with Platelet rich plasma at 
implant sites, which is regarded as a very interesting finding in 
maxillary areas,  fracture sites type IV bone and in females with 
osteoporosis. Moreover soft tissue heals better with  platelet rich plasma. 
The platelet gel  is more frequently used in reconstructive and plastic 
facial  surgery and provides greater patient comfort.  It  is  probable that 
tissue engineering and genetic therapies modify implant and 
regenerating strategies if al l  ongoing studies confirm such results.  
           
Hesham El-sharkawy et al(2007)[13], found that Growth factors were 
increased significantly in PRP compared to whole blood (WB) and 
platelet-poor plasma. Monocyte chemotactic protein -1 (MCP-1) was 
suppressed significantly by PRP, whereas regulated on activation, 
normal T-cell expressed and secreted RANTES was increased 
significantly in monocyte cultures.  LXA(4) levels were significantly 
higher in PRP compared to WB. PRP stimulated monocyte chemotaxis in 
a dose-dependent fashion, whereas RANTES, in part , was responsible 
for PRP-mediated monocyte migration. Platelet  rich plasma promotes 
regeneration of bone presumably through the action of CGF. However it  
is not clear how PRP affects the inflammatory response.  
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Dong-seoksohnet al
2 5
 (2009)[25],  found that growth factors play a 
major role to repair or generate damaged tissue. Most of growth factors 
are in blood plasma and platelet . So platelet concentrates contains 
sufficient growth factors such as platelet derive d growth factors 
(PDGF), transforming growth factor -beta (TGF-β),  Insulin-l ike growth 
factor (IGF-I), epidermal growth factor(EGF), vascular endothelial  
growth factor (VEGF), basic fibroblast growth factor (bFGF). PRP has 
widely been used in the dental  fie ld such as sinus augmentation, ridge 
augmentation, periodontal regeneration and soft tissue healing. However 
the effect  of PRP is controversary. According to one systemic review on 
the effect  of PRP, the beneficial  effects of PRP in the treatment of 
periodontal  defects is evident but evidence for beneficial effects of PRP 
in sinus elevation appeared to be weak.  
 
Dr.Manimaran et al (2010) [17], found that the properties of Platelet  
rich plasma are based on the activation and release of multiple growth 
factors upon activation. They enhance and accelerate soft tissue healing 
and bone regeneration. Owing to the availabil ity of these growth factors  
in high concentration of platelets, use of Platelet rich plasma offers 
distinct  advantages over other media containing natural or recombinant 
factors. The action of these factors are very complex because individual 
action on same tissues vary depending upon local factors and interaction 
between one another. Most of the advantages regarding PRP are sti ll  in 
research.  
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Dr.Kiran NK et al (2011)[23],  concluded that the affinity of osteoblasts 
to the PRF membrane appeared to be superior.  PRF has many advantages 
over PRP. It  eliminates the redundant process of adding anticoagulant as 
well as the need to neutralize it.  The addition of bovine derived 
thrombin to promote conversion of fibrinogen to fibrin in PRP is also 
eliminated. The elimination of these  steps considerably reduces 
biochemical handling of blood as well as risks associated with the use of 
bovine derived thrombin. Platelet rich fibrin has more advantages over 
platelet rich plasma and very favourable to the healing process due to 
slow polymerisation reaction.  
 
Dr.Kedarnath et al (2011 )Platelet -rich plasma (PRP)  is  an  autologous  
Concentration of human platelets in a small volume of plasma.  Because 
it is a concentration of platelets, it  is also  a  concentration  of  the  7  
fundamental  protein growth  factors  proved  to  be  actively  secreted  
by platelets to  initiate all  wound healing.  These growth factors  include  
3 isomers  of platelet-derived growth factors (PDGFĮĮ,  PDGFȕȕ, and 
PDGFĮȕ), 2 of the numerous transforming growth factors -ȕ (TGFȕ1 and 
TGFȕ2),  vascular  endothelial   growth  factor,   and epithelial  growth 
factor. All these growth factors have been documented to exist in 
platelets.  Because these concentrated platelets are suspended in a small 
volume of plasma, PRP  is   more  than  just  a  platelets concentrate;   it   
also  contains  the  3  proteins  in  blood known  to  act   as  cell  
adhesion  molecules  for osteoconducti on and as a matrix for bone, 
connective tissue,  and  epithelial  migration .  Platelet-rich plasma 
(PRP), the concentrate of platelets in plasma contains various Growth 
Review of Literature 
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factors that enhance osseous regeneration.Soft tissue healing differed 
significantly between PRP and NON-PRP sites.On radiographic 
evaluation significant differences were observed in the mean scores of 
radiographic density between PRP and NON-PRP sites on Photo 
Stimulating Phosphor (PSP) images and IOPA Radiographs.  
           
BalaramNaik et al  (2013)[22], conclude that  PRF first  described by 
Choukroun is a new second generation of platelet  concentrate. 
Simplified processing technique without any complex handling makes it  
superior to PRP. PRF can be used to promote wound healing, bone 
regeneration, graft  stabilization, wound sealing, and hemostasis. 
Because the fibrin matrix is better organized, it  is able to more 
efficiently direct stem cell  migration and the healing program. Release 
of growth factors from PRF through in vitro studies and good results 
from in vivo studies led to optimize the clinical application of PRF. It  
was shown that there are better results of PRF over PRP. Dohan proved 
a slower release of growth factors from PRF than PRP and observed 
better healing properties with PRF. It was observed and shown that the 
cells are able to migrate from fibrin scaffold, while some others 
demonstrated the PRF as a supportive matrix for bone morphogenetic 
protein as well.  
 
TejeshYelamali et al (2015)[15] ,  concluded that PRF is signiﬁcantly 
better in promoting soft  tissue healing and also faster regeneration of 
bone after third molar extraction, in comparison with PRP. Although, 
both PRF and PRP clinically showed very good soft  tissue healing as 
Review of Literature 
 
 
20 
 
measured by healing index of Landry et al. ,  further studies with larger 
sample size are needed to show much convincing effects of these 
biomaterials in terms of soft  tissue healing. Moreover, PRF deﬁnitely 
showed to promote better osseous regeneration over PRP in te rms of 
uniformity and density of regenerated bone which is statistically 
signiﬁcant.  Although, the present study was done with a four month 
follow-up and the osseous regeneration was only measured indirectly 
over computer PRP.aided software (Adobe Photosho p CS),  PRF did 
attribute to be a much simpler and a better platelet  concentrate, in 
promoting soft  tissue healing and osseous regeneration over PRP.  
 
Peter mansour et al (2015) [26],  concluded that during normal wound 
healing, the fibrin matrix is important  in haemostasis, however more 
crucial  is  its  role in acting as the initial  scaffold for the new 
extracellular matrix.  It  allows binding of cells and healing proteins  to 
the scaffold,  such as platelets,  WBCs, fibroblasts and osteoblasts, 
endothelial cells, and smooth muscle cells. Fibrin has also been shown 
in animal models to be an important determinant of angiogenesis,  as 
fibrin deposited in subcutaneous t issue induces angiogenesis. 
Furthermore, many studies have shown that  wound healing is largely 
dictated by fibrin structure, in density,  number of branch points, 
porosity and permeability.  The fibrin physical  structures are determined 
by many factors including clotting rate,  Factor XIII concentration, 
thrombin, chloride ions, pH, etc.  
Materials and Method 
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MATERIALS AND METHOD  
 
IRB Approval:  
 Before the start of the study, the methodology was presented to 
the IRB and approval was obtained.  
 
IRB/IEC Reference No :  2015-MD-BrIII-GOK-06/APDCH 
Sampling procedure  Random selection of population  
No. of Groups  Two   
Control group (Group 1) & Experimental group 
(Group 2)  
Sample size  15 + 15=30 
 
Patient selection:  
 Patients were selected by means of volunteers’ recruitment 
process. Patients interested in the surgical removal of mandibular 3
rd
 
molars were included in the study.  Symptomatic  and asymptomatic  
patients were selected and inform consent form signed.  
 
Inclusion criteria:  
 Partial ly erupted or Completely Impacted mandibular 3 rd  molar 
(Symptamatic or Prophylatic)  
 Patients between age of 20 -40 years  
 Absence of Active Acute infection.  
 Patients willing to participate in the study by signing the inform 
consent form.  
 Patients with healthy periodontal  status  
Materials and Method 
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EXCLUSION CRITERIA 
 Patient’s allerg ic to LA or any medication  
 Chronic Smokers and Alcoholic  
 Patient’s with Systemic disorder and Immunocomprised  patient  
 Pregnant and Lactating mother’s  
 Patients not willing to participate in t he study 
 
This prospective randomized control blind study was carried out 
to evaluate  and compare utility and efficacy of concentrated growth 
factor on soft tissue healing and bone healing following surgical 
removal of mandibular impacted 3
rd
 molar in 15 patients by fulfilling 
the inclusion and indication criteria.  All patients had moderately 
difficult impacted lower third molar according to modified Pederson’s 
index as follows,  
 
Classification                                                                           Value  
Spatial  relationship :   
Mesio angular                                                                               1  
Horizontal /  Transverse                                                                 2  
Vertical                                                                                        3  
Disto angular                                                                                4  
 
Depth:  
Level A –  High occlusal  level                                                        1  
Level B –  Medium occlusal level                                                    2  
Level C –  Low occlusal                                                                  3  
Materials and Method 
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Ramus relationship / Space available:  
Class 1 –  Sufficient space                                                             1  
Class 2 –  Reduce space                                                                 2  
Class 3 –  No space                                                                        3  
 
Difficulty index  
Very difficult                                                                              7 -10  
Moderately difficult                                                                    5 -6  
Slightly difficult                                                                          3-4 
 
Study groups:  
The selected patients were divided into 2 groups of 15 patients each.  
30 patients with mandibular 3
rd
 Impacted Mandibular 3
rd
 Molar.  
 Group- A- 15patients as study group  
 Group- B- 15 patients as control group     
 
Healthy patients with moderately difficult impacted mandibular 
third molars according to modified Pederson’s difficulty index and 
patients who were willing to accept  the  inform consent  and  willing  to  
participate  in  the  study  with  its subsequent follow -ups were included 
in this study.  
 
MATERIALS: 
A) The kit  will contain all  necessary armamentarium for the blood 
collection and CGF specific vacuette tubes (Pre -sterlized)  
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BLOOD SAMPLING KIT:  
1.  1.Antiseptic Swab 
2.  2.Throwaway Tourniquet  
3.  Butterfly venflon  
4.  4.Haemostaticband-aids 
5.  5.Vacuette test  tubes.  
 
B) Centrifuge ((Medifuge MF200, Silfradent, Forli  , Italy)  Blood phase 
separator for CGF)  
 
PLATELET PLUG CONTAINER:  
1.  Surgical Tray 
2.  Dappen for fibrin separato 
3.  Griglia per separatore  
4.  Normal saline solution  
5.  Dappen Dish 
6.  Scissors with Round tip-Cutting instrument  
7.  Straight anatomic pliers  
8.  Pliers for membrane creation.  
9.  Compactor device  
10.Surgical instrument tray.  
C)  Instruments specific to produce fibrin membrane and to insert the  
CGF in to the extraction site.  
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METHOD: 
Impaction procedure: 
Intraoral periapical  radiogrpahs  or Orthopantomogram were  
obtained  to  determine  the  type  of impaction.  Inferior  alveolar,  
lingual  and  long  buccal  nerve  anaethesia  was achieved  using  a  2ml  
solution  of  2%  lignocaine  hydrochloride  and  vasoconstrictor  
(1:80,000).   Following  a  ward’s  incision  a  full   thickness  muco 
periosteal  flap  with  releasing  incision  on  the  distobuccal  aspect  of  
the  second molar was raised. After buccal and distal  guttering the tooth 
was sectioned and gently elevated from the socket with subsequently  
flushed with normal saline and betadine. The flap was closed with 3 -0 
silk sutures in an interrupted fashion.  
 
Blood Sample Centrifugation  
1.  The patient will  be seated comfortably in the dental chair in semi 
supine position, In patient’s fore arm tourniquet  would be applied 
after Dabbing with anti septic swab. 
2.  9 mL of blood will  be drawn from the anticubital region and 
collected in sterilisedVacuette tubes (Greiner Bio -One, GmbH, 
Kremsmunster, Austria) without anticoagulant solutions .   
3.  This tube will  be immediately centrifuged in special machine 
(Medifuge MF200, Silfradent,  Forli , Italy) using a program with 
the following characteristics: 30’’ acceleration, 2’ 2,700 rpm, 4’ 
2,400 rpm, 4’ 2,700 rpm, 3’ 3,000 rpm, and 36” deceleration and 
stop.  
4.  At the end of the process there would be three blood fractions:  (1) 
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the upper platelet poor plasma (PPP) layer; (2) the middle fibrin 
rich gel with aggregated platelets and concentrated growth factors 
(CGF); (3) the lower red blood cell (RBC) layer.  
5.  Middle fibrin rich  layer along with the few mm of RBC layer 
would be cut and kept in the extraction socket and wound would 
be closed with 3-0 si lk material . If  required a plier would be used 
to create as membrane which will  be placed in the extraction 
socket.  
 
• Criteria’s to  be evaluated for the study  
-  Pain ( Visual Analogue Scale )  
-  Edema  (Comparison of pre-op & post-op measurements:  
 
1. Distance between the cornerof the mouth to ear lobule;  
2. Distance between the Ala of the nose to Angle of the mandible .  
-  Wound dehiscence (Cslinical  examination for any discharge,  
Gaping, Discoloration over the mucosa)  
-  Mouth opening  (Inter Incisal Distance in mm) (Maximum –  
45mm) 
-  Soft tissue healing- Healing index by  Landry et al  
-  Dry socket  
-  Hard tissue healing- IOPA (or) OPG 
 
PAIN: 
Pain was evaluated subjectively by Faces pain rating scale (VAS).   
This scale  combines  pictures and  numbers  to  allow  pain  to  be  
Materials and Method 
 
 
27 
 
rated  by  the patient.  The faces range from smiling face to sad and 
crying face. A numerical rating has been  assigned  to  these  faces,  
ranging  from  0  to  10  in  ascending  order, proportionate to  increase  
of  pain.  The patient is  asked to rate his or her pain using appropriate 
picture.  (Figure 1) 
 
SWELLING: 
Facial measurements and maximum mouth opening were recorded 
pre operatively.  Parameters recorded were swelling, pain,  trismus and 
quality of l i fe on 1st, 3rd, 5th and 7th day post operatively.  Facial 
swelling was measured by a modification of tape measuring method 
described by Gabka and Matsumara. Three measurements were made 
between 5 reference points. (Figure 2,3, & 4)  
1.  Tragus of the ear  
2.  Soft  tissue pogonion.   
3.  Lateral corner of the eye  
4.  Angle of the mandible  
5.  Outer corner of the mouth  
 
WOUND DEHISCENCE 
          Blanching over the mucosa, Discharge, Gaping 
 
Mouth opening  
          It  was  evaluated  by  measuring  the  distance  between  the  
mesial incisal  corners  of  the  upper  and  lower  central  incisors  of  
Right / Left  quadrant  at   maximum  mouth opening with the help of 
divider. (Figure 5) 
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SOFT TISSUE HEALING (Landry et al Index )  
A.VERY POOR: 
 Tissue colour : > 50% Gingival red  
 Response to palpation :  Bleeding  
 Granulation tissue: Present  
 Incision margin: Not epithelialized, with loss of  
     Epithelium beyond incision  
B. POOR: 
 Tissue colour : > 50% Gingival red  
 Response to palpation :  Bleeding  
 Granulation tissue: Present  
 Incision margin :Not epithelialized, with CT exposed                                
 
C. GOOD:  
 Tissue colour:  >25 and> 50% Gingival red  
 Response to palpation :  Bleeding  
 Granulation tissue: Present  
 Incison margin: Not epithelialized, with CT exposed  
 
D. VERY GOOD 
 Tissue colour  :  <25 of gingival red  
 Response to palpation: No Bleeding  
 Granulation tissue: None 
 Incision margin:  No Connective tissue exposed  
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E. EXCELLENT 
 Tissue colour: All tissues pink 
 Response to palpation :  No Bleeding  
 Granulation tissue: None 
 Incision margin: No connective tissue exposed  
 
BONE TISSUE HEALING :   
 Bone density: Pre and Post OP (IOPA or OPG)  
 Duration:  1 –  6 Months  
 No. of Radiographs:  4 (Immediate, 1 s t ,  3 r d  and 6 t h  month) 
 
Analysis of bone density:  
The bone density was assessed by DIGORA software . Digora 
software has increased sensitivity in the detection of bone changes non -
invasively.  Four digitalized OPG are taken at pre -scheduled intervals.  
The images were compared at different intervals using DIGORA 
Software.  The radiographic density differences between each interval 
were evaluated and analysed.  
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RESULTS 
Method of Statistical Analysis:  
 The data collected were compiled using MS -Office Excel and was 
subjected to Statist ical analyses were performed using IBM corp. 
Statist ical Package for Social Sciences software for windows; version 
22.0 (Armonk, NY). Data comparison was done by applying specific 
statistical  tests to find out the statistical significance of the obtained 
results. Depending upon the nature of the data, the statis tical  tests were 
chosen. P value of < 0.05 was considered to be significant.  
 
Independent sample t test was done to compare the means of Group 1 
and Group 2.  
The data analyzed by using ANOVA with unpaired T -test to 
compare the measurements of pain,  swelling, Mouth opening, soft  tissue 
healing and Hard tissue formation & between the two groups. The results 
were averaged (mean + standard deviation) for each parameter between 
the 2 groups.  
 
In all  the tests P value less than 0.05 was accep ted as statistical  
significant.None of the patients reported adverse ev ents.  Total  30 
patients in which 15 control and 15 study patients were enrolled in the 
study and randomly divided into two groups. The mean age of the 
patients was 28.90.  
 
Study Groups:  
Group A: Impacted tooth without CGF placement.  
Group B: Impacted tooth with CGF placement.  
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Observations from table1:  
Comparison of  two groups with respect to PAIN at preoperative,1
s t
 
and 7
t h
  postoperative days.  
 MEAN ± STD 
DEVIATION 
MEAN 
DIFFERENCE 
95% 
CONFIDENCE 
INTERVAL OF 
THE 
DIFFERENCE 
P 
VALUE 
 GROUP 1  GROUP 2  Lo wer  Upper  
PRE 
OPERATIVE 
7.80±.862 7.93±.799 -.133 -.755 .488 .664 
IMMEDIATE 
POST 
OPERATIVE 
5.00±.845 1.27±.594 3.733 3.187 4.280 <.001* 
AFTER 1  
WEEK 
2.20±.862 .07±.258 2.133 1.657 2.609 <.001* 
*Independent paired t test p value<0.05 = statistically significant.  
 
On Preoperative day  the mean pain scores were 7.80 in group I 
and 7.93 in group II.  
 
On 1st postoperative day  the mean pain scores observed were 
5.00in group I, 1.27 in group 2. Though t he mean pain score was 
comparatively less in group II but it  was statistically significant at 5% 
level of significance, P value was .001*.  
 
On after 1 week  the mean swelling scores were 2.20  in group 
I, .07 in group II.  Though the mean pain score was compa ratively less in 
group II but it  was statist ically significant at 5% level of significance, P 
value was less than .001*.  
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Statist ical  significant difference was observed between two groups 
with respect to swelling scores at  preoperative, 1st,  and 7th 
postoperative days at  5% level of significance (p<0.05)  
 
 
Observations from table 2:  
 Comparison of three groups with respect to EDEMA (or) 
SWELLING at preoperative, 1
s t
 and 7
t h
 post-operative days.  
 MEAN ± STD 
DEVIATION 
MEAN 
DIFFERENC
E 
95% 
CONFIDENCE 
INTERVAL OF 
THE 
DIFFERENCE 
P 
VALUE 
 GROUP 1  GROUP 2  Lo wer  Upper  
PRE OPERATIVE  12.87±.74
3 
12.60±.7
37 
.267 -.287 .820 .332 
IMMEDIATE 
POST 
OPERATIVE 
13.93±1.0
33 
8.87±1.1
25 
5.067 4.259 5.875 <.001* 
AFTER 1 WEEK 12.87±.74
3 
.00±.000 12.867 12.47
4 
13.260 <.001* 
*Independent paired t test p value<0.05 = statistically significant  
On Pre-operative  day the mean swelling scores were 12.87 in 
group I,  12.60 in group II.   
150
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On 1
s t
 post-operative  day the mean swelling scores observed were 
13.93 in group I,  8.87 in group 2.  Though the mean swelling or edema 
score was comparatively less in group II but it  was  statistically 
significant at 5% level of significance, P value was <.001*.  
On 7 th post-operative  day the mean swelling scores were 12.87 
in group I and .00 in group II.  Though the mean swelling score was 
comparatively less in group II but it  was statistically significant at 5% 
level of significance, P value was <.001*  
  
Statist ically significant difference was observed between two 
groups with respect to swelling scores at pre -operative,  1
s t
  and 7
t h
  
post-operative days at 5% level of significance (p<0.05).  
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Observations from table 3:  
 Comparison of two groups with respect to TRISMUS (or) MOUTH 
OPENING scores at preoperative, 1
s t
  and 7
t h
  post-operative days.  
 MEAN ± STD 
DEVIATION 
MEAN 
DIFFERENCE 
95% 
CONFIDENCE 
INTERVAL OF 
THE 
DIFFERENCE 
P 
VALUE 
 GROUP 1  GROUP 2  Lo wer  Upper  
PRE OPERATIVE 45.67± 
6.287 
38.60± 
7.689 
7.067 1.814 12.319 .010* 
IMMEDIATE 
POST 
OPERATIVE 
25.07± 
4.200 
35.33± 
3.599 
-10.267 -
13.192 
-7.341 <.001* 
AFTER 1 WEEK 28.20± 
4.092 
41.07± 
4.758 
-12.867 -
16.186 
-9.548 <.001* 
*Independent paired t test p value<0.05 = statistically significant  
 
On pre-operative  day the mean mouth opening scores were 
observed in 38.60 group I and 38.60 in group II.   
 
On 1
s t
 post-operative  day the mean mouth opening scores 
observed were 25.07 in group I and 35.33 in group II.  The mean mouth 
opening score was comparatively more in group II which is statistically 
significant at 5% level of significance, P value was <. 0001  
 
On 7
t h
 post-operative  day the mean mouth opening scores were 
28.20 in group I and 41.07 in group II.  The mean mouth opening score 
was comparatively more in group II which is stat istically significant at 
5% level of significance, P value was <. 001. (P<0.05)  
 
In group II pat ients mouth opening is more in comparison with group I.  
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Statist ically significant difference was observed between two 
groups on 1
s t
 and 7
t h
 post-operative days as the P value was <.001*. It  
means in group 2 patients mouth opening score is signicantly incre ased 
than group 1.  
 
When comparing the two group’s mouth opening was more in 
group II patients than group I mouth opening on 1
s t
 and 7
t h
 post-
operative days.  
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Observations from table 4:  
Comparison of three groups with respect to SOFT TISSUE 
HEALING at preoperative, 1
s t
 and 7
t h
 post-operative days.  
 MEAN ± STD 
DEVIATION 
MEAN 
DIFFERENCE 
95% 
CONFIDENCE 
INTERVAL OF 
THE 
DIFFERENCE 
P 
VALUE 
 GROUP 1  GROUP 2  Lo wer  Upper  
PRE 
OPERATIVE 
1.47±.516 1.33±.488 
.133 -.242 .509 .473 
IMMEDIATE 
POST 
OPERATIVE 
1.67±.488 2.67±.617 
-1.000 -
1.416 
-.584 <.001* 
AFTER 1 
WEEK 
3.33±.488 4.60±.507 
-1.267 -
1.639 
-.894 <.001* 
*Independent paired t test p value<0.05 = statistically significant  
 
On Preoperative day  the mean swelling scores were 1.47 in group 
I,  1.33 in group II.   
 
On 1
s t
 postoperative day  the mean swelling scores observed were 
1.67 in group I and 2.67 in group 2. Though the mean soft tissue healing 
score was comparatively more in group II but it  was   statist ically 
significant at 5% level of significance, P value was <.001*.  
 
On 7
t h
 postoperative day  the mean swelling scores were 3.33 in 
group I and 4.60 in group II. Though the mean soft tissue score was 
comparatively more in group II but it  was stati stically significant at 5% 
level of significance, P value was <.001*  
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Statist ically significant difference was observed between two 
groups with respect to soft tissue scores at pre -operative, 1
s t
  and 7
t h
  
post-operative days at 5% level of significance (p <0.05).  
 
 
Observations from table 5:   
Table5: Comparison of two groups with respect to Hard tissue 
healing at preoperative, 1
s t
,  7
t h
 day, 1
s t
 and 3
r d
 month postoperative 
period 
HARD TISSUE HEALING 
 MEAN ± STD DEVIATION  MEAN 
DIFFERENCE 
95% CONFIDENCE 
INTERVAL OF THE 
DIFFERENCE 
P 
VALUE 
 GROUP 1  GROUP 2  Lo wer  Upper  
PRE 
OPERATIVE 
178.07±15.285 181.07±13.946 
-3.000 -13.944 7.944 .579 
IMMEDIATE 
POST 
OPERATIVE 
164.13±13.809 167.13±11.594 
-3.000 -12.536 6.536 .525 
AFTER 1 
WEEK 
164.13±13.809 167.13±11.594 
-3.000 -12.536 6.536 .525 
1
S T
 MONTH 179.00±15.264 186.60±15.445 -7.600 -19.085 3.885 .186 
3
R D
 MONTH 183.27±14.801 225.40±14.836 -42.133 -53.217 -31.049 <.001* 
*Independent paired t test p value<0.05 = statistically significant  
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On Preoperative day  the mean swelling scores were 178.07 in 
group I and 181.07 in group II.   
   
On 1
s t
 postoperative day  the mean swelling scores observed were 
164.13 in group I and 167.13 in group 2. Though the mean soft t issue 
healing score was comparatively more in gro up II but it  was statist ically 
significant at 5% level of significance, P value was .579.  
 
On 7
th
 postoperative day  the mean swelling scores were 164.13 
in group I and 164.13 in group II.  Though the mean soft tissue score was 
comparatively more in group II  but it  was statistically significant at 5% 
level of significance, P value was .525  
 
On 1
s t
 month  the mean swelling scores observed were 179.00 in 
group I and 186.60 in group 2.  Though the mean soft  tissue healing 
score was comparatively more in group II b ut it  was statistically 
significant at 5% level of significance, P value was.525  
 
On 7
t h  
month  the mean swelling scores were 183.27 in group I and 
225.40 in group II.  Though the mean soft tissue score was comparatively 
more in group II but it  was statistically significant at 5% level of 
significance, P value was <.001*  
 
Statist ically significant difference was observed between two 
groups with respect to hard tissue healing scores at  pre -operative, 1
s t
  
and 7
t h
 post-operative days at 5% level of significance  (p<0.05).   
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DISCUSSION  
 
Surgical removal of impacted mandibular third molars is the most 
frequent surgical procedure performed by Oral & Maxillofacial 
surgeons. The surgery involves elevation of a soft tissue flap, followed 
by adequate bone guttering and  odontectomy.[27] These procedures 
cause a significant amount of tissue injury,  leading to the release of 
various vasoactive chemical mediators,  which initiate  the process of 
inflammation and repair.  
 
Thus, despite the diversified demands of practice,  dental  surgeons 
still  face the problem of the removal of impacted mandibu lar third 
molars [28]. Both the patient and dentist  must therefore have scientific 
evidence-based information concerning the estimated degree of surgical 
difficulty in each case [29].  
 
MacGregor [30] made the first  at tempt to establish a model for 
assessing surgical  difficulty.  The classic Pell  and Gregory classification 
has recently been found to be inadequate for the determina tion of 
surgical  difficulty [31].  
 
There are a number of previous studies carried out to evaluate 
surgical difficulty in the extraction of im pacted mandibular third molars 
(28,31,32,33,34,35,36,). However, most of these studies are only based 
on dental factors determined through radiologic assessments 
(31,32,34,35,36,).  While opinions may vary, most authors agree that  
these radiologic factors play some ro le in estimating difficulty 
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(32,33,34,35,31). Other authors believe it is difficult to estimate 
difficulty through radiologic methods alone and that actual  difficulty 
can only be estimated intraoperatively (37). Some authors also believe 
that clinical  variables, such as patient age, gender and weight, are also 
very important (33,34). Few authors have proposed indexes for 
measuring surgical difficulty (35,36 ).  Pederson proposed such an index 
(28),  but i t  is seldom used due to reports that  it  does not match a ctual 
surgical  difficulty (35,39).  
 
Surgical removal of impacted mandibular third molar causes 
significant  pain,  swelling and trismus even when done a 
traumatically.[40], [41] and is quite annoying to the patient and affects 
their quality of life by delaying the period of recovery. These 
complications are attributed to the inflammation produced as a result  of 
surgical  trauma. 
              
From 1990’s,  till  today growth factors have emerged as the “Holy 
Grail” in wound healing.[15]  Researches by Dong-seok sohn and others 
showed that  concentrated growth factors (CGF) improve bone formation 
and plays a vital role in osseointegration of implants. Growth factors 
play a major role to repair or generate t issues. Most of the growth 
factors are in blood plasma and platelets. So pl atelet concentrates 
contains sufficient growth factors such as platelet  derived growth 
factors (PDGF), Transforming growth factors (TGF - β), Insulin like 
growth factors (IGF- I), Epidermal growth factors (EGF), Vascular 
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Endothelial Growth Factors  (VEGF),  basic Fibroblast Growth Factors  
(bFGF).[25]  
 
Concentrated growth factors is known to have higher tensile 
strength, higher concentration of growth factors and higher resistance to 
flow than Platelet rich fibrin (PRF), Platelet rich plasma (PRP), and 
hence compressed CGF  can be used as barrier membrane with growth 
factors as alternative collagen membrane. This barrier membrane 
induces faster formation and fast tissue healing.[25]  
 
CGF & ITS IMPORTANCE 
Concentrated growth factors CGF (Fig -15 (A) is well known to 
accelerate new bone formation. Other blood derivatives like Platelet rich 
Plasma uses complex protocols to prepare and chemical additives.  
Concentrated growth factor, overcomes these disadvantages. CGF does 
not require any chemical or allergenic a ddit ives such as Bovine 
thrombin or anticoagulants, so is free from viral  transmission diseases.  
CGF is 100 % autologous fibrin.[24]
 
CGF can be used alone or with a 
bone graft.[42]
 
CGF with fibrin rich blocks  induce fast new bone 
formation.[43]  
 
Fabrication of CGF: 
The calibrated centrifugation carried out with the Medifuge phase 
separator (Silfradent , Italy).  The apparatus accurately designed so as to 
guarantee the maximum exploitation of the blood’s potential by 
controlling the following, Speed, Time, Temperature, acceleration and 
controlled speed and Gravitational acceleration of approximately 
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RCF200. The development and growth of the fibrin gel block during the 
centrifugation and specially during the polymerisation, al lows for a 
volume growth of the chains in all directions.[26] CGF, like PRF, does 
not require the inclusion of bovine thrombin or any  anticoagulants. 
Additionally,  altered protocols in receiving the blood sample and in the 
centrifuging procedure compare with PRF. Unlike PRF however, CGF 
uses variable rpm from 2400-2700 to separate cells in the venous blood,  
which results in fibrin rich blocks that  are larger, denser and more 
affluent in growth factors than common PRF. This shows enhanced 
regenerative capacity and superior versatility w hen using the fibrin rich 
block.[26] 
 
The CGF is characterised by four phases :  
1.  A superior phase represented by the serum (blood plasma in 
absence of fibrinogen and coagulation factors).  
2.  An interim phase represented by a very huge and dense 
polymerised fibrin block.  
3.  A liquid phase containing the Growth Factors,  white line 
cells and stem cells waiting for stimulation and to 
differentiate into specialized cell types.  
4.  A lower red portion consists of a viscous, dense, platelet -rich 
coagulation.[26]  
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The phases and their components are:  
1. Serum 
  Serum is the lightest and most liquid part  of blood. It is  
fibrinogen-free and has only a few cells. It  should be kept cool and 
mixed quickly to avoid denaturing the proteins.[26]  
It  is  a clear and straw yellow in colour and consists of:  
 92% Water 
 7% proteins, mineral  salts, Carbondioxide  
 Proteins: albumin and  antibodies  
 Nutrients:  glucides, amino acids,  lipids and  Enzymes  
 Hormones 
 Inorganic electrolytes  
 
2. Fibrin Buffy Coat  
The polymerized fibrinogen molecules (FG), the resultant fibrin 
block comprises three-dimensional polymer networks with interwoven 
fibres, all  collected in a single phase in the form of a gel in a single 
phase. During polymerisation, the fibres grow in dia meter.[26] 
 
3. The Growth Factors and the unipotent Stem Cells:  
                 Below the buffy coat and above the dense clot portion lies 
the growth factors and unipotent stem cells. This phase can be aspirated 
with a pipette and mixed with autologous bo ne to obtain an extremely 
high performance activated graft.[26] 
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4. Coagulum: 
In the CGF technique, the red phase consists of concentrated red 
and white blood cells, platelets and clotting factors. It  appears like a 
dark reddish dense gel, and can be used in its pure form or added with 
fibrin particles and/or autologous or heterologous bone when filling 
very enormous defective areas.[26]
 
 
CGF in regenerative surgery should therefore be considered as a 
multifactorial stimulation system. This versatility  and multiplicity of 
applications makes i t successful  from all  the other techniques proposed 
so far.  [26]  
 
Mode of action of CGF:  
The ensuing fibrin clot or block is of a greater quality due to the 
concentration of factor XIII,  fibrinogen and thrombin that  is  obtained. 
Factor XIIIa, which is activated by thrombin, cross links the fibrin clot 
to increase stability,  strength and protection against  plasmin mediated 
degradation. Clinically,  this results in a clot with higher tensile 
strength, adhesive strength,  and decline in haemostatic time (105 secs vs 
360 secs).[26]
 
 
Besides the tensile fibrin membrane, a red phase of concentrated 
red blood cells and platelets are obtained. This is often mixed with 
either autogenous  or other fillers for a more easy to handle and 
voluminous cavity fi lling method. In actual fact the CGF is an upgraded 
version of PRF with a strengthened fibrin matrix and boosted growth 
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factors and cytokines.[26]
 
During normal wound healing, the fibrin 
matrix is essential in arrest of bleeding, however more crucial is its role 
in acting as the initial scaffold for the new extracellular matrix. It  
allows mixing of cells and healing proteins to the scaffold, such as 
platelets, White blood corpuscles,  fibrob lasts and osteoblasts,  
endothelial cells , and smooth muscle cells.[26]
 
 
Keratinocytes bind to fibrin. By expressing sites for binding of 
cytokine, growth factors and adhesion molecules for cells, wound 
healing was indirectly promoted by fibrins. Fibrin has  also been shown 
in animal models to be an important determinant of angiogenesis,  as 
fibrin deposited in subcutaneous tissue initiates angiogenesis.[26]
 
 
In addition, studies have shown that  wound healing is largely 
dictated by fibrin structure; in density , porosity,  number of branch 
points and permeability.  The fibrin physical  structures are determined 
by many factors including clotting rate,  Factor XIII concentration, 
chloride ions,  pH, and thrombin etc.  Optimizing these conditions is  part  
of the aim of the CGF protocol.[26]
 
 
Pathological alterations of these fibrin fibers occur in diseases 
like diabetes and this clearly leads to disturbances in wound healing 
process. Thus these are the patients that are most likely to benefit from 
CGF.[26]
 
 
Further to the fact that CGF not only uses an autogenous source of 
growth factors and membrane, there are no added derived products of 
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animals as in PRP. With no anticoagulants added, the platelets begin to 
be activated naturally alongside the coagulation cascade. The r esult ing 
matrix or membrane rich in fibrin works synergistically with these 
growth factors.  [26]  
 
The present study is in accordance with the very similar studies 
conducted by Renu Kundu et al. ,  with Platelet rich plasma (PRP) on 
bone and implant stabili ty revealed  marked improvement in implant 
stability.  But the distinction is that,  with CGF, the level of enhancement 
acquired  is phenomenon and starts at  the early stages of bone healing 
and osseointegration. Also the bone density is enhanced above the 
baseline level, which could mean that bone mineralization is also 
enhanced by CGF. A more focussed study on that  subject  may shine 
light in this area.  
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CONCLUSION 
 
The results of this study indicates that  CGF is signiﬁcantly better 
in  regeneration of  bone around the surgical removal of mandibular 
molar when comparing with non -CGF groups. Although, CGF showed 
improvement in both soft tissue healing and bone formation, there is 
much differences in  bone level changes  on mesial  and distal  side  of the 
surgical  removal of impacted teeth between two groups. Though, the 
present study was done with a sixth month follow-up and the osseous 
regeneration was only measured indirectly over computer aided software 
(Digora), CGF did attribute to be a much simpler and a better platelet  
concentrate, in promoting osseous regeneration. CGF also aided in 
increasing the density of bone around the surgical  removal of impacted 
3
rd
  molar teeth from baseline to a much higher level. This attribute 
could be used in cases where bone mineralization is compromised. But 
the exact action of CGF on bone mineralization needs to be st udied 
further.  
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PICTURES: 
Figure 1: Pain (Visual analogue scale)  
 
 
MEASUREMENT OF FACIAL SWELLING  
Figure 2: Tragus to corner of mouth measurement  
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Figure 3: Tragus to pogonion measurement  
 
 
Figure 4: Lateral corner of the eye to angle of mandible  
 
 
EVALUATION OF TRISMUS  
Figure 5: Measurement of Interincisal distance  
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Figure 6: Armamentarium 
 
 
Control group pictures  
Figure 7: Intra oral peri apical radiograph  
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Figure 8: Pre-operative 
 
 
Figure 9: Incision 
 
 
Figure10: Extracted mandibular third molar  
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Figure11: Wound closure 
 
 
Experiment group pictures  
Figure 12: Pre-operative 
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Figure 13: Pre- OPG  
 
 
Figure 14: Tooth exposed 
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Figure 15: CGF PLACEMENT 
              15 (A)                                       15(B) 
  
15(C) 
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Figure 16: CLOSURE 
 
 
Figure 17: POST OPG 
 
NAME DATE
OP NO AGE
ADDRESS
SEX
DATE OF BIRTH
OCCUPATION
CHIEF COMPLAINT
HISTORY OF PRESENTING ILLNESS
PAIN SWELLING
PAIN SWELLING Site
Location Site
Character Size
Severity Shape
Duration Colour
Aggravating Factors Edge
Relieving Factors Number
Spontaneity Pulsation
Diurnal Variation
Peristalsis
Repiration 
Postural Variation
Coughing
Deglutition
Skin Over the 
Swelling
PAST MEDICAL HISTORY
PAST SURGICAL HISTORY
Adhiparasakthi Dental College & Hospital
Department Of Oral & Maxillofacial Surgery
Impaction Case Sheet
PAST DENTAL HISTORY
PERSONAL HISTORY
FAMILY HISTORY
GENERAL EXAMINATION
Temperature
Blood Pressure
Pulse
Respiratory Rate
Gait
Orientation
Build
Nourishment
Pallor
Cyanosis
Icterus
Clubbing
Pedal Edema
General
Lymphadenopathy
Others
EXTRA ORAL EXAMINATION
Extra Oral Swelling      Yes     No     
If Yes – Describe
INSPECTION
SITE
SIZE
SHAPE
COLOUR
EDGE
NUMBER
PULSATION
PERISTALSIS
REPIRATION 
COUGHING
DEGLUTITION
SKIN OVER THE 
SWELLING
PALPATION
INSECTORY FINDINGS
TEMPERATURE
TENDERNEESS
SIZE
SHAPE
EXTENT
SURFACE
EDGE
FLUCTUATION
TRANSLUCENCY
IMPULSE ON 
COUGHING
REDUCIBILITY
COMPRESSIBILITY
PULSALITY
FIXATION
RELATIONS
PERCUSSION
FINDINGS
AUSCULTATION
FINDINGS
TMJ Examination   Tenderness    Clicking    Crepitus    Deviation    Any Other Abnormality
Specify Other Abnormalities
Rima Oris   Macrostomia    Normal    Microstomia
INTRA ORAL EXAMINATION
Teeth Present
Tongue :    Macroglossia    Normal    Microglossia ( Specify If Any Other Abnormality Detected )
Mouth Opening Trismus Present / Absent
Eruption Status   Erupted   Partially Erupted   Non Erupted
Tooth Type Of Impaction   Soft Tissue      Bony
Third Molar 
Periodontal Status
Second Molar 
Periodontal Status
Third Molar 
Caries & Vitality
Second Molar
Caries & Vitality
Third Molar 
Restorative Status
Pericoronitis    Yes      No  
Position & Thickness 
Of External Oblique 
Ridge
Reason For 
Extraction
  Pericoronitis 
  Periodontitis 
  Associated Cyst / Tumor 
  Caries
  Prosthetic Reason
  Orthodontic Reasons
  Involvement In Fracture Line
  Prior To Orthognathic Surgery
Others
INVESTIGATIONS
Routine Blood Investigations
  Bleeding Time
  Clotting Time
  Random Blood Glucose
  Hemoglobin
  HIV
  HbsAg
  HCV
  Others
 Specify :
Radiographs
  Intra Oral Periapical Radiograph
  Ortho Pan Tomography
  CT
  CBCT
  Others
 Specify :
INTERPRETATION OF RADIOGRAPHS
Bone Sclerosis   Yes   No
Tooth Lock   Yes   No
Shape Of Crown
Root Formation   Completed   Not Completed
Number Of Roots
Ankylosis   Yes   No
Hypercementosis   Yes   No
Width Of The PDL Space   Less   Normal   Increased 
Distal Bone Loss   Yes   No
Root Pattern   Loss & Slender   Short & Stout
Divergence Of Roots   Yes   No
Bulbosity Of Roots   Yes   No
Dilaceration   Yes   No
Follicular Space   Present   Absent
Others
WINTER’S WAR LINES (1926)
White Line
Amber Line
Red Line
Others
MODIFIED PEDERSON’S SCORING (1988)
Spatial Relationship Relation With Ramus Relative Depth
Mesioangular – 1 Class I – 1 Position A - 1
Vertical – 2 Class II – 2 Position B - 2
Horizontal – 3 Class III - 3 Position C - 3
Distoangular – 4
Difficulty Score :
Slightly Difficult : 3 - 4
Moderately Difficult : 5 - 6
Very Difficult : 7 - 10
Others
SCORING DETAILS FOR WHARFE’S ASSESSMENT
Winter’s classification
Horizontal 2
Distoangular 2
Mesioangular 1
Vertical 0
Height of the mandible
1 - 30 mm 0
31 – 34 mm 1
35 – 39 mm 2
Angulation of second molar
1 – 59 ° 0
60 – 69 ° 1
70 – 79 ° 2
80 – 89 ° 3
>90 ° 4
Root shape
Complex 1
Favourable curvature 2
Unfavourable curvature 3
Follicle Size
Normal 0
Possible enlarged 1
Enlarged 2
Path of exit
Space available 0
Distal cusps covered 1
Mesial cusps covered 2
Both covered 3
TOTAL SCORE
OTHERS
PELL & GREGORY’S CLASSIFICATION (1933)
A. Relation Of The Tooth To The Ramus Of The Mandible & 2nd Molar
  Class I
  Class II
  Class III
B. Relative Depth Of The Third Molar In Bone
  Position A
  Position B
  Position C
C. The Position Of The Long Axis Of The Impacted Mandibular Third In Relation To The Long Axis Of The Second 
Molar (Winter’s Classification)
  Vertical
  Horizontal
  Inverted
  Mesioangular
  Distoangular
  Buccoangular
  Linguoangular
Any Of These May Also Occur In
  Buccal Version
  Lingual Version
  Torsi Version
Others
RELATIONSHIP TO THE INFERIOR ALVEOLAR CANAL (HOWE & PONTON 1960 ROOD’S & SHEHAB 1990)
A. Related But Not Involving The Canal
  Separated
  Adjacent
  Superimposed
B. Related To Changes In The Canal
  Darkening Of The Root
  Dark & Bifid Root
  Narrowing Of The Root
  Deflected Root
C. Related With Changes In The Canal
  Interruption Of Lines
  Converging Canal
  Diverted Canals
PROCEDURE
Type Of Anesthesia    LA    LA + Sedation   GA
Sedation ( If Used )    Oral    Inhalational   IV
LA Administered
Incision & Flap
   Terence Ward
   Modified Ward
   Envelope
   Other Types ( Specify )
Bone Cutting Techniques    Bur    Chisel 
Odontectomy    Yes    No 
Delivery Of Tooth    Forceps    Elevator 
Duration Of Surgery
Operative Notes
OTHERS :
CLOSURE
Styptics Used    Abgel    Bone Wax    Others   None
Sutures Used    Absorbable                                               Non Absorbable 
PERIOPERATIVE ASSESSMENT
Patient Co Operation    Good    Adequate    Poor
Mouth Opening    Satisfactory    Not Satisfactory
Gag Reflex    Yes    No 
Adequate Pain Control Achieved    Yes    No 
Others
MODIFIED PARANT SCALE (1997)
Easy 1 Extraction Requiring Forceps Only
Easy 2 Extraction Requiring Osteotomy Only
Hard 3 Extractions Requiring Osteotomy & Coronal Section
Difficult 4 Complex Extractions (Requiring Root Resection)
POST OPERATIVE MEDICATION
Antibiotic Used Dose / Route Duration
Corticosteroids Dose / Route Duration
Analgesics Dose / Route Duration
Enzyme    Yes    No 
POST OPERATIVE REVIEW
1ST Visit Date 1ST Visit Time No Of Post Op Days
Oedema    Yes    No 
Wound Healing Status
Dehiscence Of Socket    Yes    No 
Trismus    Yes    No 
Dry Socket    Yes    No 
Parasthesia    Yes    No    Lingual    Mental    Both 
Any Other Associated Symptom
2nd Visit If Required
JR CONSULTANT HOD
Adhiparasakthi Dental College & Hospital 
Consent Form for the evaluation of early accelerated tissue healing in the 
surgically removed impacted mandibular 3
rd
 molar socket using concentrated 
growth factors 
                                                                                                                      Date:                
Name of the patient: 
Age / Sex: 
OP Number: 
The evaluation procedure of the early accelerated tissue healing in the surgically 
removed impacted 3
rd
 molar teeth socket has been explained to me and I have also had 
the opportunity to have my doubts answered satisfactorily. The operating procedures, 
alternatives, advantages and disadvantages have been discussed including the 
consequences of not having the surgical procedure. I also understand the results of my 
clinical examination, proposed treatment plan(s), possible complications and 
anticipated results. I voluntarily accept any or all possible risks that may be associated 
with any part of these procedures. I understand it is my duty to diligently follow the 
instructions given to me in regard to the procedure. I testify that I have read the consent 
form and give my consent form for the treatment. 
 
Signature of the patient                                                             Signature of the doctor 
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                                        EVALUATION CHART DETAILS 
1. PAIN - VISUAL ANALOGUE SCALE 
 
2. EDEMA (Measuring with tape or 2-0 Nylon thread) 
1.Distance between the corner of the mouth to ear lobule 
2. Distance between the Ala of the nose to Angle of the mandible 
3. WOUND DEHISCENCE 
          Discoloration over the mucosa, Discharge, Gaping 
4.Mouth opening (Scale) 
Distance between the Incisal edges of the upper and lower central incisors.  
5. SOFT TISSUE HEALING (Landry et al Index) 
A.VERY POOR: 
         Tissue colour : > 50% Gingival red 
2 
 
         Response to palpation : Bleeding 
         Granulation tissue : Present 
         Incision margin : Not epithelialized, with loss of epithelium beyond incision 
B. POOR: 
         Tissue colour: > 50% Gingival red 
         Response to palpation: Bleeding 
         Granulation tissue: Present 
      Incision margin: Not epithelialized, with CT exposed                                
C. GOOD:  
        Tissue colour :  >25 and > 50% Gingival red 
        Response to palpation: Bleedings 
        Granulation tissue: Present 
        Incison margin: Not epithelialized, with CT exposed 
D. VERY GOOD 
Tissue colour : <25 of gingival red 
Response to palpation: No Bleeding 
Granulation tissue: None 
Incision margin: No Connective tissue exposed 
 
3 
 
E. EXCELLENT 
        Tissue colour: All tissues pink 
        Response to palpation: No Bleeding 
        Granulation tissue: None 
        Incision margin: No connective tissue exposed 
 
   5.  BONE TISSUE HEALING: Bone density 
             PRE and Post OP (IOPA or OPG)  
 
 
 
 
INSTITUTIONAL ETHICS COMMITTEE AND REVIEW BOARD 
 
 Inform IEC/IRB immediately in case of any issue(s) / adverse events. 
 Inform IEC/IRB in case of any change of study procedure, site and 
investigator. 
 Annual report to be submitted to IEC/IRB. 
 Members of IEC/IRB have right to monitor the trial with prior intimation. 
 
ADHIPARASAKTHI DENTAL COLLEGE AND 
HOSPITAL 
Melmaruvathur, Tamilnadu-603019 
MEMBERS 
Dr.K.Rajkumar, BSc, MDS. 
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